Search Results
Found 1 results
510(k) Data Aggregation
(315 days)
PERFINT HEALTHCARE PVT LTD
MAXIO™ is a user controlled, stereotactic accessory intended to assist in the planning and manual advancement of one or more instruments during Computed Tomography (CT) guided percutaneous procedures.
MAXIO™ permits physician verification of patient position prior to needle advancement and monitoring of respiratory levels during the procedure. Image registration and overlay tools available in MAXIO™ are intended to provide guidance to the user during planning and instrument placement.
MAXIO™ is indicated for use with rigid straight instruments such as needles and probes used in Computed Tomography (CT) guided percutaneous interventional procedures performed by physicians trained for CT procedures on organs and anatomical structures in the thorax, abdomen and pelvis.
MAXIO™ is an image-guided, physician controlled stereotactic accessory to a Computed Tomography (CT) system, intended for the stereotactic spatial positioning and orientation of an end effector and instrument guide to assist in manual advancement of one or more instruments such as rigid straight needles and probes during CT guided percutaneous procedures on organs and anatomical structures in the thorax, abdomen and pelvis.
MAXIOTM System provides pre-operative planning assistance to the physician by creating a reconstructed 3D image model of received CT data and by visually representing the planned instrument path and position(s) of one or more instruments on the model, along with performance data provided by the instrument manufacturer or as specified by the user.
MAXIO™ permits physician verification of patient position prior to needle advancement and monitoring of respiratory for levels during the procedure. Image registration and overlay tools available in MAXIO™ are intended to provide guidance to the user during planning and instrument placement. MAXIOTM is intended to be used by physicians trained for CT procedures.
MAXIO" consists of a stereotactic device and its accessories, software loaded on a computer, and a respiratory gating system. The accessories include a patient immobilizer and skin-markers. MAXIO™ System uses single use sterile disposables viz, end effector, instrument guide and drapes.
Here's a breakdown of the acceptance criteria and the studies that prove MAXIO™ meets them, based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria / Performance Aspect | Reported Device Performance (Study Finding) |
---|---|
Accuracy Targets | Met (demonstrated through bench tests using static phantom) |
Segmentation Accuracy | Demonstrated (through adequate bench testing and clinical experience) |
Registration Accuracy | Demonstrated (through adequate bench testing and clinical experience) |
Usability | Conducted in accordance with HE75 AAMI / ANSI HE75:2009 (Human factors engineering) |
Safety (Electrical) | Performed in accordance with IEC 60601-1, 3rd edition |
Safety (EMI/EMC) | Performed in accordance with IEC 60601-1-2, 3rd edition |
Laser Pointer Compliance | Complies with 21CFR1040.10 and 1040.11 |
Biocompatibility of Disposables | Tested in accordance with ISO 10993-1 |
Sterilization, Packaging, Shelf Life (Disposables) | Meet all relevant/applicable IEC and FDA standards |
Ability to intervene (patient movement) | Tested (at Memorial Sloan Kettering Cancer Center) |
Effectiveness of skin marker/laser alignment for patient movement | Verified (under a CRO supervised study) |
Correlation between skin marker and anatomy for anatomical accuracy | Verified (under a CRO supervised study) |
Accuracy and Repeatability (stereotactic performance) | Demonstrated (through analysis of 170 CT Guided Interventions, a 20-patient liver ablation study, and an animal study) |
Accurate needle placement (liver ablation) | Demonstrated (in a 20-patient liver ablation study) |
Accuracy of needle placement (comparable to expert freehand) | Demonstrated (in an animal study) |
Reduced needle manipulations, check-scans (compared to expert freehand) | Demonstrated (in an animal study) |
2. Sample Size Used for the Test Set and Data Provenance
- 170 CT Guided Interventions:
- Sample Size: 170 needle placements
- Provenance: Outside of the USA (retrospective analysis of interventions performed by users of MAXIO™)
- 20-Patient Liver Ablation Study:
- Sample Size: 20 patients, 40 tumors
- Provenance: University of Malaya Medical Center, Kuala Lumpur (likely prospective)
- CRO-supervised study on skin marker/laser alignment:
- Sample Size: 14 patients
- Provenance: Global Hospitals, Chennai, India (likely prospective)
- Animal Study (needle placement accuracy):
- Sample Size: 6 animal liver targets, 35 needle placements
- Provenance: Memorial Sloan Kettering Cancer Center (likely prospective)
- Bench Tests: Used static phantom, not human or animal data.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications
The document does not explicitly state the number of experts used to establish ground truth or their specific qualifications for any of the studies mentioned. It generally refers to "qualified users" or "physicians trained for CT procedures." For the animal study, it mentions comparison to "freehand placement by experts," implying expert involvement but not quantifying or qualifying them.
4. Adjudication Method for the Test Set
The document does not specify any formal adjudication method (e.g., 2+1, 3+1) for establishing ground truth in any of the studies.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
- Was it done? The document mentions an animal study where "the accuracy of needle placement with MAXIO assistance is comparable to freehand placement by experts however fewer needle manipulations, check-scans." This implies a comparison between human performance (experts doing freehand) and human performance with AI assistance (MAXIO™ assistance).
- Effect size of how much human readers improve with AI vs. without AI assistance: The document states "fewer needle manipulations, check-scans" with MAXIO™ assistance compared to expert freehand. It doesn't provide a quantitative "effect size" or specific percentage of improvement, but rather a qualitative benefit in procedural efficiency.
6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study
The accuracy targets, segmentation accuracy, and registration accuracy were demonstrated through "bench tests" using a "static phantom." This portion of the evaluation appears to be a standalone assessment of the device's capabilities without human intervention, focusing on its technical precision.
7. Type of Ground Truth Used
- Bench Tests (Accuracy, Segmentation, Registration): Likely based on precisely known measurements from a static phantom and potentially expert-defined benchmarks or measurements for segmentation/registration.
- Clinical/Animal Studies:
- Needle Placement Accuracy: Most likely determined by subsequent imaging (e.g., CT scans) to verify the actual needle tip position relative to the planned target, along with clinical outcomes or observations during the procedure. The "accurate needle placement using MAXIO for CT guided Tumor ablations" in the 20-patient study points to this.
- Patient Movement Detection/Correlation: Verified through direct observation, measuring shifts, and comparing skin marker data to anatomical movement in CT scans.
- Needle Manipulations/Check-scans: Direct observation and recording during the procedures.
8. Sample Size for the Training Set
The document does not provide any information about a training set or its sample size. The studies described are primarily for validation of the device's performance.
9. How the Ground Truth for the Training Set Was Established
Since no training set is described, there's no information on how its ground truth was established.
Ask a specific question about this device
Page 1 of 1